The Campbell’s Company (NYSE: CPB) — The Soup Half Works, the $8B Snacks Bet Doesn’t: Cheapest-Ever, but the “E” Is Still Falling

Independent equity research. This is general information and analysis, not investment advice. No recommendation or price target appears outside the clearly-labeled “Claude’s Take” block below.

As-of date: 2026-07-03 · Price: $23.32 (2026-07-02 close) · Market cap: ~$7.0B · Enterprise value: ~$13.6B · Net debt: ~$6.66B · Shares: ~300M (→~306M FY26 incl. La Regina) · FY end: late July · Dividend: $1.56/yr (~6.7% yield)

⚡ Claude’s Take

This block is the author’s own subjective opinion. It is general information, not investment advice. Everything in the analytical body (sections 1–15) below carries no position or price target.

Verdict: HOLD / accumulate-on-weakness / not-a-short. A genuinely cheap, cash-generative staple with one working half (Meals & Beverages, led by Rao’s) strapped to one broken half (Snacks) and a 3.7x-levered, all-goodwill balance sheet. Conviction: medium. Directional fair-value zone ~$21–27 — roughly 8x EV/EBITDA on a stabilized ~$1.7B EBITDA base net of ~$7B debt, or ~10x a normalized ~$2.30–2.50 adjusted EPS. Against $23.32 today the stock is roughly fairly-to-modestly-cheaply priced for what it is, not the screaming bargain the 3rd-percentile-of-its-own-history P/S and P/B imply. I’d add sub-$21 (where the dividend yield clears ~7.5%, the FCF yield exceeds 12%, and the CAG-style deep-value asymmetry appears); I’d trim into the high-$20s absent evidence that Snacks margins have genuinely bottomed.

The tension is specific, and it is why CPB is more interesting than the average broken staple. On price it screens with the cheapest cohort in Big Food — 0.70x sales (3rd percentile of its own decade), ~7.8x EV/EBITDA, ~10.6x forward earnings, a ~6.7% dividend that is frozen but covered (~1.5x by free cash flow, unlike Conagra’s threatened 9.8%). On quality it is a below-average, ~9%-ROIC business whose earnings are actively falling — FY26 adjusted EPS guided to $2.15–2.25, down ~25% from FY25’s ~$2.99 — because the Snacks division management bought (Snyder’s-Lance 2018, ~$6.1B) has seen its EBIT margin collapse ~400bp to ~10%, and the FY27 setup is genuinely grim (5–6% total inflation if oil stays near $100). The stock looks cheaper than it is precisely because the denominator is shrinking. What separates CPB from the terminal-decline names (KHC, CAG) is that half the company works: Meals & Beverages consumption is slightly positive, the at-home-cooking trend is a real tailwind, condensed-soup-as-a-cooking-ingredient is growing, and Rao’s is a legitimate #1-premium-sauce franchise with pricing power. That gives management a credible self-help path — shrink and fix Snacks, lean on M&B — that Conagra lacks. My framing is therefore deep-value / abandoned-defensive with a live self-help option, not “quality staple mean-reverts.” The tape agrees on the first half: zero market beta, negative risk-adjusted returns at every horizon out to ten years, a −60% max drawdown — a textbook falling knife — that has, for the first time, caught a bid (m3 +7.7% off the April $20 low).

Conviction: medium. The single fact that flips me bullish: two consecutive quarters of year-over-year Snacks EBIT-margin expansion (not just sequential), proving the ~10% floor is real and the mix/simplification plan is working. The single fact that flips me bearish: a dividend cut or a hybrid-debt issuance that signals the balance sheet — not choice — is now driving the equity, or M&B consumption rolling back over (removing the one thing that works). Tag: “Two halves, one balance sheet — the soup earns its keep, the snacks are on probation.”

📈 Stock Price Action — Five-Year Event Map

Factual price history, not a recommendation. Price moves are Facts; attributed drivers are Interpretation.

Over five years CPB has round-tripped and then broken down: from ~$44 in mid-2021 it rose to an all-time-area high of $57.55 (Dec 2022) as the bear-market defensive bid crowded into low-beta staples, then bled steadily to a five-year low of $20.00 (Apr 2026) — a ~65% peak-to-trough decline — before a modest bounce to $23.32 today. The stock now sits ~59% below its 2022 peak, near the bottom of its 52-week range ($20.00–$34.03), and ~17% above its April low.

Cycle narrative. (1) The pandemic pantry-loading demand pull-forward reversed while input inflation compressed gross margin, starting the de-rate off 2021 levels. (2) In the falling 2022 equity market, investors crowded into low-beta staples; CPB’s near-zero market beta made it a haven and, combined with inflation-era pricing that stuck, drove it to a $57.55 peak (2022-12-27). (3) Once list-pricing was exhausted, volumes fell as consumers traded down; a broad bond-proxy staples de-rate (rising rates) erased the premium through 2023. (4) FY24 was defined by the ~$2.7B Sovos/Rao’s acquisition (re-levering to 4.3x) and the symbolic November-2024 rename dropping “Soup”; the stock held a $42–52 range as the market waited to judge the deal. (5) Through 2025 the Snacks division’s margin structure fell apart (segment EBIT toward ~7–10% vs ~14%), producing repeated guidance cuts, while the secular narrative (GLP-1, private label, center-store decline) took over — driving the stock to $28. (6) In 2026 the FY26 guide-down to $2.15–2.25 adjusted EPS plus a Strait-of-Hormuz oil-inflation scare pushed the shares to a cheapest-ever $20.00 (2026-04-14); a modest recovery followed as the Q3 print beat on EPS and the tape found a short-term floor. (Price history only — the opportunity judgment sits in Claude’s Take above.)

1. Executive Summary

The Campbell’s Company (renamed from Campbell Soup Company in November 2024) is a ~$10.3B-revenue North-American packaged-food maker organized into two roughly equal segments: Meals & Beverages (Campbell’s soup, Rao’s, Prego, Pace, Pacific, V8, Swanson) and Snacks (Pepperidge Farm/Goldfish, Snyder’s-Lance pretzels, Kettle/Cape Cod chips, Late July, Pop Secret). Founded in 1869 and still ~30% owned by the Dorrance founding family, it is a low-growth, moderately-moated, heavily-indebted staple trading at the cheapest valuation in its own decade.

The investment debate is unusually clean because the company is genuinely two businesses. The Meals & Beverages half works: consumption is slightly positive, the at-home-cooking trend is a durable tailwind, condensed soup used as a cooking ingredient (>50% of the condensed line) is growing, and Rao’s is a legitimate premium-sauce franchise with pricing power. The Snacks half is broken: segment operating margin has fallen ~400bp to ~10%, salty snacks are losing share to Frito-Lay, and the 2018 Snyder’s-Lance acquisition thesis — buy growth in snacking — has failed, confirmed by ~$305M of cumulative goodwill/intangible impairments in FY24–25.

The numbers tell a consistent story of a below-average business at a trough price. FY25 gross margin was 30.4%, down ~400bp from 34.5% in FY20; ROIC is ~9.1% and falling toward a ~7–8% cost of capital; net leverage is 3.7x (down from a 4.6x post-Sovos peak); and FY26 adjusted EPS is guided to $2.15–2.25, a ~25% decline from FY25’s ~$2.99, as Snacks margin pressure and cost inflation overwhelm productivity. Yet the cash generation is real (~$705M FCF, ~10% FCF yield) and the ~6.7% dividend is frozen but covered ~1.5x. At $23.32 the stock trades at ~7.8x EV/EBITDA, ~10.6x forward earnings, and 0.70x sales — the 3rd–8th percentile of its own ten-year history — with a factor profile (zero beta, negative risk-adjusted returns at every horizon, −60% drawdown) that marks a textbook falling knife which has only just caught a bid.

The valuation embeds roughly flat-to-slightly-declining perpetual real earnings — less punitive than Conagra’s ~−3% but consistent with a business where one half decays and the other holds. The bull case is that a cash-generative staple at a decade-trough multiple, with a working M&B half and a credible Snacks self-help plan, is mispriced for permanent decline. The bear case — held by the tape, a BofA Underperform (PT $18), and three sell-side targets below the current price — is that this is a levered, ex-growth, sub-cost-of-capital business early in a Kraft-Heinz-style value-trap, where each year of falling EPS re-anchors “cheap” lower. This memo takes no position; the sections below lay out the evidence for both.

2. Business Overview

Campbell’s makes and markets branded, shelf-stable and snack food and beverages, almost entirely in the United States and Canada (international soups/beverages were divested in FY2020). Revenue is split across two reported segments of similar size.

Meals & Beverages (~50% of sales, ~$5.2B). The historic core. It includes Campbell’s condensed and ready-to-serve (RTS) soups; Swanson broths and stocks; Pacific Foods broths, soups and non-dairy beverages; Prego pasta sauces; Pace Mexican sauces; Rao’s premium Italian sauces (acquired via Sovos, 2024); Campbell’s gravies, dinner sauces and canned pasta; Swanson canned poultry; and V8 juices. Management has reframed this segment around a resilient consumer behavior — at-home cooking — rather than “soup.” Roughly half the condensed-soup line is bought as a cooking ingredient (e.g., cream of mushroom in casseroles), and that use-case is growing even as mainstream eating RTS soup declines. Rao’s and Pacific occupy the growing premium end of RTS (~20% of that line).

Snacks (~50% of sales, ~$5.0B). Built through the 2018 Snyder’s-Lance acquisition and Pepperidge Farm. Brands include Goldfish crackers, Pepperidge Farm cookies (Milano) and fresh bakery, Snyder’s of Hanover pretzels, Lance sandwich crackers, Cape Cod and Kettle Brand potato chips, Late July organic snacks, Snack Factory Pretzel Crisps and Pop Secret popcorn. Management now describes the strategy as owning four “$1B+ power brands” (Campbell’s, Rao’s, Goldfish, Pepperidge Farm) and simplifying the long tail of smaller brands and SKUs.

How it makes money. Campbell’s sells to grocery, mass, club, dollar, convenience, drug and e-commerce channels, largely through direct-store-delivery (DSD) for snacks and warehouse distribution for meals. Revenue is overwhelmingly recurring in the sense that it is repeat-purchase consumable staples, but it is non-contractual — there is no subscription lock-in; volume depends on brand preference, shelf placement, promotion and price gaps versus private label. The economic engine is: buy commodities (wheat, tomatoes, aluminum, oils, cocoa, energy/logistics), convert them into branded product at ~30% gross margin, and spend ~15–16% of sales on SG&A and marketing to defend shelf and share.

Verdict: A mature, scale-driven North-American branded-food operator with a genuinely bifurcated portfolio — a stabilizing, premium-tilting Meals & Beverages half and a margin-impaired, share-losing Snacks half.

3. Industry Dynamics

Packaged food in North America is a structurally below-average industry — a low-growth, low-real-return, capital-cycle-mature category with several secular headwinds. It is defensive (non-cyclical demand, low beta) but not attractive in the Greenwald sense of protected excess returns.

Market size and growth. U.S. center-store packaged food is a large, mature category growing roughly with population plus modest pricing — low-single-digit nominal, flat-to-negative in real volume. After the 2021–2023 inflation surge, when the entire industry pushed double-digit list pricing that consumers initially absorbed, the elasticity finally bit: volumes fell as shoppers traded down, and pricing power is now largely exhausted. The forward algorithm for the group is ~flat volume + low-single-digit price, i.e., low-single-digit revenue at best.

Competitive intensity and profit pools. The industry is an oligopoly of large branded players (Campbell’s, Conagra, General Mills, Kraft Heinz, Mondelez, PepsiCo/Frito-Lay, Smucker, McCormick) competing for finite shelf space against an increasingly credible private-label threat. In salty snacks specifically, PepsiCo’s Frito-Lay is a dominant, DSD-advantaged incumbent whose scale makes it very hard for a #3/#4 player like Snyder’s-Lance/Kettle to earn attractive returns. Retailer power (Walmart, Costco, Kroger, dollar channels) is high and rising, compressing supplier margins through trade-spend demands.

Secular headwinds. Three overhang the whole group: (1) private-label share gains as retailers upgrade own-brand quality and value-seeking consumers trade down; (2) GLP-1 / weight-management drugs as a demand risk for calorie-dense center-store and snack categories (magnitude debated, direction not); and (3) health/“better-for-you” migration away from processed, sodium-heavy legacy products (canned soup, mainstream salty snacks). Against these, the tailwinds are narrower: at-home cooking (a value behavior in a stretched-consumer economy that favors soup, broth, sauces) and premiumization in select brands (Rao’s, Kettle).

Regulation and inputs. Light product regulation (FDA labeling, sodium scrutiny) but heavy input-cost exposure — wheat, tomatoes, oils, cocoa, aluminum cans, and energy/diesel logistics. The FY27 setup is a live example: management flagged base inflation ~3% plus an incremental 2–3% if oil holds near $100 (Strait-of-Hormuz risk), driving aluminum, packaging, freight and fertilizer costs — a 5–6% total inflation year that productivity alone cannot fully offset.

Capital cycle (Marathon lens). The industry sits in the unattractive phase for legacy center-store: no capacity additions, but demand is flat-to-declining and returns are mean-reverting toward cost of capital. Capital has, if anything, been misallocated — the 2015–2019 M&A wave (Snyder’s-Lance, Pinnacle, Kraft-Heinz) chased scale and “snacking growth” at high multiples and has been serially impaired since. There is no supply-side tightening to underwrite a cyclical recovery; the only path to value creation is self-help (cost, mix, brand focus).

Verdict: structurally below-average industry — defensive and cash-generative, but low-growth, low-return, and facing genuine secular demand pressure. The correct valuation lens is EV/EBITDA, P/S, and free-cash-flow/dividend yield — not GAAP P/E (impairment-distorted) or P/B (negative tangible equity).

4. Competitive Position

Campbell’s moat is narrow and bifurcated — real in pockets, absent in others — and, critically, not wide enough to have prevented ROIC from compressing toward the cost of capital.

Where the moat is real (demand captivity + brand):

• Campbell’s condensed soup. Campbell’s holds a dominant (~60%+) share of U.S. condensed soup, a position built over a century and anchored by the cooking-ingredient use case — “cream of mushroom” is a habitual recipe input with low ticket, high repeat, and genuine brand-recipe lock-in (consumers cook to the brand). This is Greenwald demand captivity via habit. But the category is small and no longer growing on the eating side; the moat protects a shrinking pool.
• Rao’s. The single best asset in the portfolio. Rao’s is the #1 premium jarred pasta-sauce brand, with a genuine quality reputation, real pricing power, and a growth trajectory that has held through the downturn. It is the reason the Sovos deal, despite the leverage, is defensible.
• Goldfish. The #1 kids’ baked cracker, a niche with real brand preference (parents buy the brand), decent margins, and — after two quarters of core-focus stabilization — a plausible return to growth. A narrow but real moat.

Where there is no moat:

• Salty snacks (Snyder’s, Kettle, Cape Cod, Lance). These are subscale #3/#4 positions in categories dominated by Frito-Lay’s DSD scale. There is no structural cost or demand advantage; the products compete on price, promotion and shelf, and they are losing share. The ~400bp segment-margin collapse is the financial confession that this half has no protected returns.
• Mainstream RTS soup, V8, canned pasta. Legacy brands in secular decline, exposed to private label and health migration.

The market-share-stability and ROIC tests (Greenwald). A true moat shows up as stable share and persistent excess ROIC. Campbell’s fails both at the enterprise level: aggregate share is eroding in snacks, and ROIC has fallen from ~11.7% (FY23) to ~9.1% (FY25), converging on a ~7–8% WACC. A ~9% return on a business this mature, against ~30% gross margins that are themselves compressing, is the signature of a business whose “moat” no longer generates meaningful economic profit at the consolidated level. The good assets (Rao’s, Goldfish, condensed-for-cooking) are cross-subsidizing the bad (salty snacks, mainstream RTS).

Verdict: a narrow, eroding moat — genuine demand captivity in a handful of brands, none of it wide enough to protect consolidated returns. This is a collection of a few good franchises and a lot of average-to-poor ones, not a durable wide-moat compounder. Say it plainly: at ~9% ROIC converging on WACC, the enterprise moat is not currently producing durable excess returns.

5. Growth History and Forward Opportunities

History: growth has been bought, not earned. Reported revenue rose from $8.69B (FY20) to $10.25B (FY25), but the walk is almost entirely acquisition and price, not organic volume:

• FY20→FY22: revenue actually fell then recovered ($8.69B → $8.48B → $8.56B) — pandemic pull-forward and normalization, flat underlying.
• FY23→FY24: the step to $9.36B → $9.64B reflects pricing and the partial-year Sovos contribution.
• FY25: $10.25B is the first full year of Rao’s/Sovos — the ~$600M increase is overwhelmingly the acquisition; organic sales were roughly flat-to-slightly-down.

Strip out M&A and price, and organic volume has been flat-to-negative for years — the defining feature of the whole legacy-packaged-food cohort. FY26 guidance confirms it: organic net sales −1% to −2%, with management explicitly steering to the lower (−2%) end.

Forward opportunities — real but modest, and margin-first, not volume-first:

1. Meals & Beverages momentum (the credible one). M&B consumption is slightly positive and management expects it to hold. The levers are genuine: at-home-cooking resilience, condensed-soup-as-ingredient growth, Rao’s and Pacific premium RTS growth, and a “condensed sauces” innovation extending the cooking use-case into new flavors. This half can plausibly grow low-single-digits.
2. Goldfish back to growth. Stabilized core (−1/−2%) with a path to positive via household-with-kids focus, multipack price-pack architecture (multipacks +6% in the latest 13 weeks), and bigger, fewer innovations. The most profitable snack brand — getting it to growth is the single biggest Snacks lever.
3. Snacks simplification / margin recovery. SKU-tail rationalization, network/node consolidation, and RGM (revenue growth management) — cutting low-ROI trade promotions (walking away from shelf-only TPRs, concentrating on feature-and-display). This is a margin story (recover the ~400bp lost), not a volume story.
4. La Regina in-sourcing. Bringing the Rao’s co-manufacturer’s margin in-house adds ~70–80bp to gross margin from Q4 FY26 — a real, if small, structural benefit (at the cost of ~7M dilutive shares).

What is NOT a forward driver: M&A (explicitly “off the table” while deleveraging), international expansion (divested), and list-price-led growth (exhausted; pricing is now a “last resort” cost-recovery tool, not a growth lever).

Verdict: low-quality, low-magnitude growth. The realistic algorithm is flat-to-down organic volume, low-single-digit price, and a margin-recovery self-help story where the value creation would come from getting Snacks EBIT back toward mid-teens — not from top-line growth. This is a stabilization-and-cost story, not a growth story.

6. Financial Quality

Revenue and margins. FY25 revenue $10.25B; gross margin 30.4%, down ~400bp from 34.5% in FY20 — the clearest quantitative evidence of the moat’s erosion, driven by input inflation the company could not fully price and by Snacks mix deterioration. Operating margin 13.2% (vs ~15% FY20–21); EBITDA margin 17.4%. Within the total, the segment split is the story: Meals & Beverages holds mid-teens-to-higher margins, while Snacks EBIT margin collapsed to ~10% (Q3 FY26), from ~14% a year earlier (and a ~7% Q2 FY26 trough) — a ~400bp YoY decline management calls “not acceptable.”

Earnings and quality-of-earnings. GAAP diluted EPS was $2.01 (FY25), depressed by $176M of impairments and higher interest; adjusted EPS (the company’s non-GAAP, which backs out impairments, deal/integration and restructuring) was ~$2.99. The gap is legitimate to watch but not a red flag — the adjustments are genuinely non-recurring (impairments, Sovos integration). The more important QoE point is direction, not GAAP-vs-adjusted: adjusted EPS is guided down to $2.15–2.25 in FY26, a ~25% decline, because the Snacks margin loss and 5–6% FY27-facing inflation overwhelm the $100M SG&A takeout. Cash conversion is healthy — operating cash flow ($1,131M FY25) exceeds net income by ~1.9x — so the earnings are cash-backed; the problem is the level and trajectory of earnings power, not its cash quality.

Free cash flow. FY25 OCF $1,131M less capex $426M = $705M FCF (~10% FCF yield on the ~$7B market cap), ~$2.37/share. Dividends of $459M leave ~$246M for debt paydown. Capex has run ~$370–517M (4–5% of sales) — a moderately capital-hungry business (plants, DSD, ERP). FCF comfortably covers the dividend (~1.5x), which is the crux of why the payout — though frozen — is not, today, at Conagra-style cut risk.

Returns on capital. ROIC ~9.1% (FY25), down from 11.7% (FY23) and ~11% (FY20–22), converging on a ~7–8% WACC — a business earning barely more than its cost of capital. ROE 13.0% and ROA 4.0%; note ROE is flattered by a thin, goodwill-heavy equity base and should not be read as a quality signal. Read ROIC, not ROE.

Balance sheet. This is the pressure point. Total debt $7.21B; cash $132M; net debt $6.66B; net debt/EBITDA 3.7x — down from a 4.6x post-Sovos peak (FY24) but still elevated for a low-growth staple. EBITDA/interest coverage 5.2x (adequate, not comfortable). Current ratio 0.77 (normal for the sector). Investment-grade rated (BBB/Baa2), and management has made maintaining IG an explicit imperative, targeting “low 3s” leverage within ~2 years via working-capital reduction, capex discipline, a frozen dividend, and possibly hybrid debt (50% equity credit). Tangible book value is deeply negative (−$18/share) — goodwill $4.99B + intangibles $4.36B against $3.9B equity — which is why P/B (1.7x) and P/TBV are meaningless here; use EV/EBITDA and P/S.

Verdict: do economics improve with scale? No — they have deteriorated. Margins, ROIC and earnings power have all fallen over five years despite a larger revenue base, because the incremental scale (Snacks) came in below the company’s own returns and levered the balance sheet. The saving grace is genuine, cash-backed free cash flow and an investment-grade (if stretched) balance sheet. This is a cash-generative but economically-eroding business.

7. Capital Allocation

Campbell’s capital-allocation record over the past decade is poor, and the current posture — correct as it is — is best understood as forced clean-up rather than chosen strategy.

The acquisitions that defined (and impaired) the company:

• Snyder’s-Lance (2018, ~$6.1B). Created the Snacks division and the leverage that still constrains the company. Eight years on, the segment’s margin has collapsed and share is eroding — the thesis (buy secular snacking growth) has not delivered, and the impairments confirm overpayment.
• Sovos Brands / Rao’s (FY24, ~$2.7B). The best of the deals — Rao’s is a genuine premium franchise growing through the downturn — but it re-levered a balance sheet that had only just been deleveraged, to 4.3x, at the top of the food-M&A cycle.
• Cumulative impairments FY24–25 (~$305M) and the November-2024 rename dropping “Soup” are, together, the tacit admission that the snacking pivot has under-delivered.

Shareholder returns. The dividend is the priority for the Dorrance-anchored register: ~$1.56/share (~6.7% yield), covered ~1.5x by FCF, but frozen — management stated flatly it has “no intention of increasing the dividend anytime soon,” balancing the payout against deleveraging. Buybacks are minimal (net ~$60M FY25, largely offsetting SBC dilution) and are effectively suspended while deleveraging. Share count is rising modestly (~299M→~306M FY26) due to ~7M shares issued for the La Regina acquisition — a rare, mechanical dilution.

The current playbook (Q3 FY26 call). Deleverage to “low 3s” over ~2 years; $100M SG&A takeout via early-retirement (fast-forwarded into FY27); capex to highest-priority projects only; aggressive working-capital reduction; M&A “off the table”; possible hybrid-debt issuance to defend the IG rating. This is the right response to an over-levered, low-return position — but it is defensive, and it forecloses the reinvestment/return optionality a healthier balance sheet would offer.

Incentives and insiders. No discretionary open-market insider purchases at the five-year low — a notable absence of conviction signaling. Recent Form 4 activity is routine (annual director grants; a Dorrance-family trust restructuring, code J, not a market signal). The Dorrance family’s ~30% block aligns management toward dividend continuity and IG preservation — supportive for income holders, but also a structural bias toward defending the status quo rather than radical restructuring (e.g., a Snacks spin/sale).

Verdict: a weak historical record (levered up for snacking growth that didn’t earn its cost of capital), now in a disciplined but balance-sheet-forced clean-up. The verdict on management’s judgment is negative on the M&A, cautiously positive on the current focus-and-deleverage posture. Watch whether they resist re-levering the moment leverage hits the low 3s.

8. Changes and Headwinds — Last Two Years

Strategic / corporate.

• Sovos/Rao’s acquisition closed (Mar 2024) — the defining recent transaction; strong brand, heavy leverage.
• Rename to “The Campbell’s Company” (Nov 2024) — dropping “Soup” to signal the meals+snacks identity.
• La Regina in-sourcing (FY26) — partial acquisition of the Rao’s co-manufacturer; +70–80bp gross margin from Q4 FY26, ~7M dilutive shares.
• Leadership. Mick Beekhuizen (former CFO) is CEO; Todd Cunfer is CFO. June-2026 8-K: EVP/Chief Enterprise Transformation Officer Daniel Poland to depart (Aug 2026) — churn in the transformation office mid-turnaround.

Operational / financial.

• Snacks margin collapse — segment EBIT to ~7–10% from ~14%, the central negative development, driving repeated guidance cuts through 2025–2026.
• FY26 guide-down — adjusted EPS to $2.15–2.25 (from ~$2.99 FY25); organic sales −1% to −2%, steered to the low end.
• Cost inflation re-accelerating — management’s FY27 warning of 5–6% total inflation (3% base + 2–3% oil/Hormuz-linked), plus a $40M incentive-comp reset and higher marketing — a materially tougher setup.
• $100M SG&A takeout / early-retirement program — the cost response, partially pulled into FY27.

External / macro.

• Tariff dynamics: a modest ~$0.03–0.04/share Q4 FY26 tariff refund (Rao’s/La Regina imports), offset by fuel/logistics inflation.
• GLP-1 and private-label pressure intensified as narratives across the group; UBS flagged a “tough” packaged-food setup (weak demand, rising costs).
• Sell-side turned more negative post-Q3: BofA Underperform (PT $18), Morgan Stanley EW (PT $21), RBC SP (PT $21), William Blair Market Perform.

Verdict: on balance these developments weaken the near-term thesis — the Snacks deterioration and inflation re-acceleration are real and have driven the earnings reset — but they also mark the recognition phase (impairments taken, dividend frozen, deleveraging prioritized, portfolio simplification begun) that typically precedes stabilization. The M&B stabilization is the one genuine positive.

9. Risk Analysis (Risk Matrix)

The dominant risks are operational and secular, not solvency: a Snacks margin that fails to recover and an inflation year that forces further earnings cuts, against a balance sheet with limited slack. Catastrophic loss is remote; the realistic bear outcome is a slow, value-trap-style bleed, not a blow-up.

10. Valuation Discussion (Embedded Expectations)

No price target; no recommendation. Multiples and scenarios only.

Where the stock trades (own-history and peer context). At $23.32 CPB trades at ~7.8x EV/EBITDA (FY25 EBITDA $1.79B; ~8x on a declining FY26 base), ~10.6x forward adjusted EPS ($2.20), 0.70x sales, and a ~6.7% dividend / ~10% FCF yield. On AZI’s own-history percentiles it is at the 8th percentile composite (P/E 18th, P/B 3rd, P/S 3rd) — the cheapest end of its own decade. GAAP P/E (~11.5x trailing) is distorted by impairments; P/B is meaningless (negative tangible equity). The honest lenses — EV/EBITDA, P/S, FCF/dividend yield — all say cheap versus its own past.

Peer comparison (public data, at respective recent dates):

CPB sits in the cheap-levered-ex-growth cluster with CAG and KHC — near the bottom of the group on EV/EBITDA and P/S, at a mid-single-digit dividend yield. It is not as cheap as CAG on P/S, and its dividend is better-covered than CAG’s (frozen ~6.7% vs a threatened ~9.8%), but its earnings are falling faster right now (FY26 −25%). Versus GIS/SJM it is cheaper on sales and yields more, reflecting its worse trajectory and Snacks impairment.

Embedded-expectations math. A simple reverse view: at ~$13.6B EV against ~$1.35B EBIT and a ~24% tax rate, the market pays ~13x EV/NOPAT. On an equity basis, ~$7.0B market cap against ~$350–500M of post-dividend FCFE growing ~0–1% solves, at an ~8% cost of equity, to roughly flat-to-slightly-positive perpetual growth. In plain terms: the market is pricing CPB for roughly flat-to-slightly-declining real earnings in perpetuity — less punitive than Conagra (~−3%) but consistent with a business where one half stabilizes and the other slowly decays. The current price does not require a recovery; it requires the earnings base to stop falling somewhere near here.

Scenario analysis (illustrative, EV/EBITDA + normalized-EPS anchored):

• Bear (~$15–18): Snacks margin keeps eroding, FY27 inflation isn’t offset, EBITDA falls toward ~$1.5B and adj EPS toward ~$1.90; the market re-rates to ~7x EV/EBITDA on a lower base and/or the dividend is cut. This is the value-trap path (KHC/CAG rhyme) and matches the BofA/MS/RBC $18–21 targets.
• Base (~$21–27): Snacks margin stabilizes near ~10–11%, M&B grows low-single-digits, EBITDA holds ~$1.7B, adj EPS normalizes ~$2.30–2.50; ~8x EV/EBITDA / ~10x EPS. Roughly fair value, i.e., the stock is priced about right for a stabilized version of today.
• Bull (~$30–36): the self-help works — Snacks EBIT recovers toward mid-teens over 2–3 years, M&B compounds, deleveraging to low-3s de-risks the equity, and the multiple re-rates toward the group/own-history midpoint (~9–10x EV/EBITDA, ~13x EPS on ~$2.60+). This requires two consecutive quarters of YoY Snacks margin expansion to become credible.

Verdict: The stock is priced at a decade-trough multiple that embeds roughly flat-to-slightly-declining perpetual earnings. It is cheap versus its own history but fairly priced for its trajectory — the classic cheap-but-falling-E setup. The asymmetry improves materially below ~$21 (bear case largely priced, >7.5% yield, >12% FCF yield); above the high-$20s the market is already paying for a stabilization that has not yet shown up in YoY Snacks margins.

11. Variant Perception

Consensus view. The sell-side and the tape agree: this is a levered, ex-growth, secularly-challenged staple whose earnings are still falling, and whose Snacks division is structurally impaired. Three post-Q3 price targets ($18–21) sit below the current price; the factor model shows negative risk-adjusted returns at every horizon out to ten years and a −60% drawdown. Consensus is that “cheap” is a trap because the E keeps falling — the Kraft-Heinz/Conagra template.

The strongest bull case. A cash-generative, investment-grade staple at the cheapest multiple in its own decade, with a frozen-but-covered 6.7% dividend and ~10% FCF yield, where half the company demonstrably works (M&B consumption positive, Rao’s growing, condensed-for-cooking growing) and the broken half (Snacks) has a specific, already-in-motion self-help plan (SKU simplification, RGM/trade-spend optimization, network consolidation, Goldfish-to-growth). The market is capitalizing permanent decline across the whole enterprise when the decline is concentrated in one segment that management is actively shrinking and fixing. If Snacks EBIT merely stops falling and M&B holds, the earnings base stabilizes near here and the stock is worth more than the ~flat-perpetuity price implies.

The strongest bear case. This is early-innings Kraft-Heinz. ROIC (~9%) is converging on WACC; gross margin has fallen 400bp in five years with no evidence it has bottomed; the FY27 inflation setup (5–6%) will force another down year; the dividend is frozen because the balance sheet (3.7x, IG imperative) can’t support growth; management is issuing shares (La Regina) and mulling hybrid debt rather than buying back stock at a trough; and the “self-help” is a multi-year margin-recovery story with no proof yet (Snacks is “worse before better” on management’s own words). Each year of falling EPS re-anchors “cheap” lower — the definition of a value trap.

The 3–5 assumptions that matter most:

1. Does Snacks EBIT margin bottom near ~10% and recover, or keep eroding? (The single most important variable — it’s ~half the company.)
2. Does M&B stay positive? (The one working half; if it rolls over, the whole thesis breaks.)
3. Is FY27 a one-off inflation air-pocket, or the start of another multi-year earnings grind?
4. Does the ~6.7% dividend hold? (Coverage is ~1.5x today but thin if EBITDA falls; a cut would confirm the value-trap read and re-rate the stock down.)
5. Does management deleverage to low-3s and stay disciplined — or re-lever for the next deal the moment it can?

Falsification evidence. The bull is falsified by two more quarters of YoY Snacks-margin decline and/or M&B turning negative — proof the erosion is enterprise-wide and secular. The bear is falsified by two consecutive quarters of YoY Snacks-margin expansion with M&B still positive — proof the ~10% floor is real and the self-help is working.

Factor-positioning read (input, not a call). The tape marks CPB as a zero-beta, abandoned-defensive falling knife: negative alpha (−0.17), negative Sharpe at every horizon 1–10 years, −60% max drawdown, and heavy Consumer-Staples-Titans loading. Crucially, the underperformance is idiosyncratic — staples and value did not fall this hard — so this is a company-specific de-rating, not a factor headwind waiting to reverse. The one new signal is the m3 +7.7% bounce off the April $20 low (Sharpe 1.05), the first positive momentum window in years — consistent with a knife that has found a short-term floor but not yet a trend. This supports the “deep-value/abandoned-defensive with a live self-help option” framing over “quality staple mean-reverts.”

12. Fact vs. Interpretation Table

13. Open Questions

1. Where does Snacks EBIT margin actually bottom — is ~10% the floor, or does salty-snack share loss push it lower before simplification helps?
2. How much of the $100M SG&A takeout lands in FY27, and is it enough to offset 5–6% inflation + the $40M comp reset?
3. What is the real normalized adjusted-EPS power once inflation normalizes and Snacks stabilizes — $2.30? $2.50? $2.60?
4. Will management hold the dividend through an FY27 inflation year if EBITDA dips, or freeze/cut to protect the IG rating?
5. Is a Snacks divestiture/spin ever on the table to unlock the M&B/Rao’s franchise value — or does the Dorrance block prefer the status quo?
6. How large and durable is the tariff-refund benefit, and will retailers claw it back?
7. What is the segment-level revenue and margin split precisely (the 10-K/10-Q detail) — needed to value the two halves separately (a sum-of-the-parts is the natural next step).

14. What Must Be True

Bull case — what must be true (and its falsification test):

• Snacks EBIT margin bottoms near ~10% and begins a multi-year recovery toward mid-teens; M&B stays positive; the earnings base stabilizes near ~$2.30–2.50 and re-rates. Falsification: two consecutive quarters of YoY Snacks-margin decline, or M&B consumption turning negative, would prove the erosion is enterprise-wide and secular — killing the bull.

Bear case — what must be true (and its falsification test):

• ROIC keeps sliding through WACC, FY27 inflation forces another EPS cut, Snacks share loss continues, and the dividend eventually breaks — the Kraft-Heinz value-trap path where “cheap” re-anchors lower each year. Falsification: two consecutive quarters of YoY Snacks-margin expansion with M&B still positive, plus visible deleveraging to low-3s with the dividend intact, would prove the floor is real and the self-help is working — killing the bear.

The crux both cases share: the direction of Snacks EBIT margin over the next 2–4 quarters. It is ~half the company, it is where all the damage is, and it is the variable that decides whether “cheapest-ever” is an opportunity or a trap.

15. Source Appendix

See the accompanying Source Appendix for the full citation list — SEC filings (FY25 10-K, FY26 10-Qs, 8-Ks, DEF 14A, Form 4 corpus), the Q3 FY26 earnings-call transcript, ROIC.ai fundamentals, AZI price/news feeds, FactorsToday factor data, and prior peer coverage (CAG, GIS, SJM, KHC, MKC, KDP, HSY).

APPENDIX A — Standard Diligence Questionnaire

The Campbell’s Company (NYSE: CPB) — as of 2026-07-03

Supplemental to the memo. Fact / Interpretation / Assumption labels applied where it matters.

General

What thoughtful questions have other investors asked? The dominant question is whether CPB is a Kraft-Heinz/Conagra-style value trap or a genuine self-help stabilization. Sub-questions: (1) has the Snyder’s-Lance/snacking strategy structurally failed? (2) Is the ~6.7% dividend safe at 3.7x leverage? (3) What is normalized adjusted EPS once inflation normalizes? (4) Would a Snacks divestiture unlock the Rao’s/M&B franchise? (5) Is Rao’s growth durable or a premium-cycle peak?

Cyclicality & Earnings Nature

Cyclical high or low? Low (Interpretation). FY26 adjusted EPS ($2.15–2.25) is ~25% below FY25 (~$2.99) on Snacks-margin collapse + inflation — a trough-ish level, though “trough” assumes Snacks stabilizes. External or internal drivers? Both: external (input inflation, private-label/GLP-1 demand) and internal (the bought-and-broken Snacks division, self-inflicted bakery execution). Revenue stability? High demand stability (non-cyclical staples, zero beta) but flat-to-negative organic volume and exhausted pricing → low-single-digit-at-best revenue. Market outlook? Mature/declining center-store; growing pockets (at-home cooking, premium RTS, kids’ crackers). Predominantly domestic (US/Canada); international divested.

Business Quality & Competitive Moat

Industry more/less competitive? More — private label rising, retailer power high, Frito-Lay dominant in salty. Profitability (ROIC/ROE)? ROIC ~9.1% (falling toward ~7–8% WACC); ROE 13.0% (flattered by thin goodwill-heavy equity — read ROIC). Industry profitability / barriers? Oligopoly with modest brand/scale barriers but no protection from secular volume decline; below-average returns. Easily understood? Yes — a two-segment branded-food company. Undermined by foreign low-cost labor? No (perishable/branded/domestic supply chains). Do brands matter? Yes in pockets (Rao’s, Goldfish, Campbell’s condensed-for-cooking); much less in salty snacks and mainstream RTS. Nature of competition? Brand, shelf/DSD, price-gap vs private label, trade promotion. Switching costs? Low/habitual — repeat-purchase preference, not contractual lock-in.

Financial Condition & Balance Sheet

Assets not on the balance sheet? The Rao’s/Goldfish/Campbell’s brand equity is under-stated relative to carrying goodwill/intangibles (Interpretation). Off-balance-sheet liabilities? Operating leases (capitalized), pension (~$199M net liability), and normal trade/co-man commitments; nothing alarming. Accounting conservatism? Adjusted EPS excludes impairments/integration — legitimate but watch the gap; cash conversion (OCF ~1.9x NI) is healthy and confirms earnings are cash-backed. CapEx-hungry? Moderately — ~$370–517M/yr (~4–5% of sales); management is now trimming to highest-priority projects.

Capital Allocation & Management

FCF and its use? ~$705M FCF (FY25); ~$459M to dividends, remainder to debt paydown; buybacks minimal (offset SBC). Philosophy? Dividend-first (Dorrance-anchored), now deleverage-first — freeze dividend, cut capex/working capital, no M&A. Recent acquisitions? Sovos/Rao’s (~$2.7B, FY24); Snyder’s-Lance (~$6.1B, 2018); La Regina in-sourcing (FY26, ~7M shares). Buybacks? Effectively suspended while deleveraging; share count rising modestly. Issuing shares to insiders? Routine SBC + ~7M La Regina shares; no aggressive insider issuance. Comp / director motivation? Standard packaged-food incentive structure; a $40M incentive-comp reset flagged for FY27. Management motivation? Defend IG rating, deleverage to low-3s, protect dividend; CEO Beekhuizen (ex-CFO) + CFO Cunfer running a disciplined clean-up. No insider open-market buying at the trough — no conviction signal.

Valuation & Market Data

ADR/MLP/K-1? No — ordinary US C-corp common stock (NYSE/NASDAQ-listed common). Dividend policy? ~$1.56/share (~6.7% yield), frozen, covered ~1.5x by FCF; ~71% payout of adjusted EPS. Profitability? Below-average (ROIC ~9%, net margin ~5.9%). Net income vs cash from operations diverging? OCF exceeds NI (~1.9x) — favorable; GAAP NI is depressed by non-cash impairments, so cash overstates GAAP earnings but fairly reflects adjusted earnings power.

Risks & Downside

What would cause the stock to decline? Further Snacks-margin erosion; an FY27 inflation year that forces another EPS cut; a dividend cut; M&B rolling over; another impairment; a broad staples de-rate. Catastrophic loss risk? Low — IG-rated, ~$700M FCF, ~$4B in $1B+ power brands. Total loss? Very low — no plausible solvency path; the realistic downside is a slow value-trap bleed, not a wipeout.

Recent News & Events

Environment changed recently? Yes — FY26 guide-down to $2.15–2.25 adj EPS (2026-06-08); Q3 adj EPS $0.50 beat but sales missed; management warned of 5–6% FY27 inflation; sell-side turned negative (BofA PT $18, MS/RBC $21). Significant acquisitions? La Regina in-sourcing (FY26); no new large M&A (“off the table”). Accounting-policy changes? None material. Recent changes? Rename to “The Campbell’s Company” (Nov 2024); Chief Transformation Officer departure (Aug 2026); $100M SG&A/early-retirement program; portfolio/SKU simplification underway.

APPENDIX B — Source Appendix

The Campbell’s Company (NYSE: CPB) — as of 2026-07-03

Primary sources first. Facts reconciled to SEC filings where possible; third-party aggregators (ROIC.ai, AZI, FactorsToday) used for computed ratios/prices and cross-checked. Management commentary treated as hypothesis, validated against filings and financials.

Primary — SEC filings (EDGAR CIK 0000016732; corpus mirrored to output/CPB/sources/)

• FY2025 Form 10-K (fiscal year ended 2025-07-31) — income statement, balance sheet, cash flow, segment detail, debt schedule, impairments. https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000016732&type=10-K
• FY2026 Form 10-Q filings (Q1 filed ~Dec 2025, Q2 ~Mar 2026, Q3 filed 2026-06-08) — quarterly financials, segment margins, La Regina disclosure.
• 8-K, 2026-06-08 — Q3 FY26 earnings release, press release, slide presentation, prepared remarks. https://www.sec.gov/Archives/edgar/data/16732/000001673226000010/cpb-20260608.htm
• 8-K, 2026-06-17 — Item 5.02, departure of EVP/Chief Enterprise Transformation Officer Daniel Poland (eff. 2026-08-03). https://www.sec.gov/Archives/edgar/data/16732/000001673226000014/cpb-20260617.htm
• DEF 14A (proxy) — executive/director compensation, incentive metrics, ownership (Dorrance family block).
• Form 4 corpus (166 filings) — insider transactions; incl. 2026-05-21 Mary Alice Dorrance Malone trust restructuring (code J) and 2026-06-30 routine director grants (code A). No open-market purchases (code P) at the trough.
• 10-K filings FY2021–FY2024 — multi-year trend, Snyder’s-Lance/Sovos acquisition accounting, prior impairments, rename.

Primary — management commentary

• Q3 FY2026 earnings-call transcript (2026-06-08) via ROIC.ai get_latest_earnings_call — FY27 inflation guidance (5–6%), Snacks margin (~10% vs ~14%), M&B consumption, dividend/leverage posture, hybrid-debt consideration, RGM/trade-spend, La Regina, tariff refund, FY26 EPS ($2.15–2.25).

Quantitative aggregators (computed data; reconciled to filings)

• ROIC.ai MCP — income statement, balance sheet, cash flow, profitability/credit/per-share ratios, enterprise value, valuation multiples (FY2020–FY2025); company profile.
• AZI feeds — price CSV (5-yr OHLCV, EMAs, beta) via download-data.php; valuation_index own-history percentiles (composite 8.1th, P/E 18.2th, P/B 3.1th, P/S 3.1th); news feed (Q3 print, analyst actions).
• FactorsToday — stock-loadings (Consumer Staples Titans 0.60, market ~0.47), leaderboard (negative Sharpe all horizons to 10y, −60% max DD, m3 +34.7% ann.), stock-info (beta ~0.01, alpha −0.17, rs_12m −20.8%), related-stocks (GIS/SJM/KHC/MKC/CAG).

Secondary — analyst / trade press (via AZI news feed, 2026-06-08/09)

• Benzinga: Q3 adj EPS $0.50 beat / sales $2.366B miss; FY26 adj EPS affirmed $2.15–2.25.
• BofA Securities — Underperform, PT lowered to $18 (2026-06-09).
• Morgan Stanley — Equal-Weight, PT $21 (2026-06-05).
• RBC Capital — Sector Perform, PT $21 (2026-06-09).
• William Blair — initiated Market Perform (2026-06-23).
• UBS — “tough” packaged-food setup (weak demand, rising costs) (2026-06-02).

Analytical frameworks (peer cross-read)

• Public packaged-food peers (Conagra, General Mills, Smucker, Kraft Heinz, McCormick, Keurig Dr Pepper, Hershey) — peer valuation, industry framing, GLP-1/private-label context, from public filings and market data.
• Greenwald (moat taxonomy, ROIC/share-stability tests, demand captivity) and Marathon capital-cycle lenses applied in the Industry, Competitive Position and Capital Allocation sections.

Key computed figures (this report)

• Price $23.32 (2026-07-02); market cap ~$7.0B; net debt ~$6.66B; EV ~$13.6B; shares ~300M (→~306M FY26).
• FY25: sales $10,253M; GM 30.4%; EBIT $1,353M; EBITDA $1,787M; GAAP EPS $2.01; adj EPS ~$2.99; NI $602M; FCF $705M.
• Leverage 3.7x net; EBITDA/interest 5.2x; ROIC 9.1%; ROE 13.0%; dividend $1.56 (~6.7%).
• Valuation: ~7.8x EV/EBITDA, ~10.6x fwd adj P/E, 0.70x sales; own-history composite 8th percentile.
• 5-yr price: peak $57.55 (2022-12-27), low $20.00 (2026-04-14).

Third-party estimates and computed ratios are labeled as such and are not primary; where they conflict with a filing, the filing governs. No analyst price target is adopted as our own (none appears outside Claude’s Take).